[ Price : $8.95]
The Biotechnology Innovation Organization says its congressional lobbying priorities for September are reauthorization of the FDA ...[ Price : $8.95]
FDA warns Chinas Jiangsu Kerbio Technology Group Co. about its violations of good laboratory practice regulations for nonclinical ...[ Price : $8.95]
FDA grants Santersus a breakthrough device designation for its NucleoCapture blood purification system for patients with severe, t...[ Price : $8.95]
Inovio Pharmaceuticals begins a rolling BLA submission for INO-3107, an experimental DNA medicine for recurrent respiratory papill...[ Price : $8.95]
CBER suspends Valneva Austrias BLA for Ixchiq (chikungunya vaccine, live) due to serious safety concerns related to the vaccine.[ Price : $8.95]
An FDA clinical trial finds that daily use of cannabidiol at levels typically used by consumers can cause elevated liver enzymes i...[ Price : $8.95]
FDA accepts for priority review a Gamida Cell supplemental BLA for omidubicel and its use in severe aplastic anemia.[ Price : $8.95]
FDA grants Quest Diagnostics a breakthrough device designation for its Haystack MRD test, a liquid biopsy designed to detect minim...